176 related articles for article (PubMed ID: 5450347)
21. [Use of anabolic preparations in atherosclerotic cardiosclerosis].
Agapova EN; Tkachenko AM; Krutovskaia OV
Klin Med (Mosk); 1974 Jan; 52(1):42-4. PubMed ID: 4466884
[No Abstract] [Full Text] [Related]
22. The influence of Clofibrat on plasma lipid levels.
Szostak WB; Cybulska B; Ruzyllo E
Mater Med Pol; 1971; 3(4):12-4. PubMed ID: 5162168
[No Abstract] [Full Text] [Related]
23. [Clinico-experimental studies of the influence of Atherolip on lipid and carbohydrate metabolism].
Hammerl H; Kränzl C; Pichler O; Studlar M
Med Welt; 1969 Aug; 31():1715-7. PubMed ID: 4895455
[No Abstract] [Full Text] [Related]
24. [Use of the complex method of Il'k, Dodik and Iovanovich for diagnosis of humoral lipid disorders in coronary atherosclerosis].
Fomina LF; Sulava SG; Sulava PV
Ter Arkh; 1968 Jun; 40(6):61-3. PubMed ID: 5739211
[No Abstract] [Full Text] [Related]
25. [Prolonged use of atromid in patients with coronary arteriosclerosis].
Zadionchenko VS
Kardiologiia; 1967 Oct; 7(10):32-5. PubMed ID: 5607197
[No Abstract] [Full Text] [Related]
26. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
De Michelis S; Paparella P; Seu V
Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
[No Abstract] [Full Text] [Related]
27. [On the nutritional problems of patients with ischemic heart disease].
Válek J; Brodan V; Pechar J; Vavrinková H; Marecková O
Cesk Gastroenterol Vyz; 1968 Oct; 22(7):477-85. PubMed ID: 5704001
[No Abstract] [Full Text] [Related]
28. [Certain aspects of lipid metabolism in patients with coronary atherosclerosis and the effect of diet therapy on the former].
Paramonova EG; Shaternikov VA
Ter Arkh; 1966 Dec; 39(12):46-50. PubMed ID: 6004395
[No Abstract] [Full Text] [Related]
29. [Drugs for hyperlipemia].
Murakami M; Sekimoto H; Masuda S; Nagai T; Iwaki N
Naika; 1968 Oct; 22(4):877-85. PubMed ID: 5710974
[No Abstract] [Full Text] [Related]
30. [Behavior of lipid metabolism in patients with peripheral arteriosclerosis].
Schmidt HH; Heine H; Friedel W; Ahlert G; Jaruszewski H
Z Gesamte Inn Med; 1968 Feb; 23(4):53-6. PubMed ID: 5686876
[No Abstract] [Full Text] [Related]
31. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
[No Abstract] [Full Text] [Related]
32. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
Hague W; Forder P; Simes J; Hunt D; Tonkin A;
Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
[TBL] [Abstract][Full Text] [Related]
33. [Seasonal fluctuations in lipid metabolism indices].
Krylov AA; Ovsiannikov IF
Voen Med Zh; 1975 Jan; (1):38-41. PubMed ID: 1114735
[No Abstract] [Full Text] [Related]
34. [Comparative study of mucopolysaccharides and lipids in coronary arteriosclerosis and acute coronary insufficiency].
Stark VM
Kardiologiia; 1967 Jun; 7(6):82-7. PubMed ID: 4236295
[No Abstract] [Full Text] [Related]
35. Rationale for use of lipid-lowering drugs.
Dayton S
Fed Proc; 1971; 30(3):849-56. PubMed ID: 5575297
[No Abstract] [Full Text] [Related]
36. [Use of nerobol in combination with potassium salts in patients with chronic coronary insufficiency].
Leshchinskiĭ LA; Kharitonova VV
Klin Med (Mosk); 1970 Oct; 48(10):38-42. PubMed ID: 5505243
[No Abstract] [Full Text] [Related]
37. Serum lipid fractions and risk of coronary heart disease. The Framingham study.
Kannel WB; Castelli WP; McNamara PM
Minn Med; 1969 Aug; 52(8):1225-30. PubMed ID: 5804989
[No Abstract] [Full Text] [Related]
38. [Certain indicators of lipid metabolism in erythrocytic membranes and plasma in coronary arteriosclerosis and myocardial infarct].
Borinskiĭ IuN; Sidorenkov MI
Sov Med; 1975 Oct; (10):143-5. PubMed ID: 1209320
[No Abstract] [Full Text] [Related]
39. [Certain aspects of lipid metabolism in patients with coronary atherosclerosis and the effect of diet therapy on it].
Paramonova EG; Shaternikov VA
Ter Arkh; 1966 Dec; 38(12):46-50. PubMed ID: 6003268
[No Abstract] [Full Text] [Related]
40. [Inborn errors of lipid metabolism. Effect of clofibrate on the level of blood lipids of patients with familial hyperlipoproteinemia (type 2, 3 and 4)].
Sobra J; Heyrovský A; Sulc M; Horáková D
Cas Lek Cesk; 1969 Aug; 108(36):1065-9. PubMed ID: 5807234
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
